The aim of the current review was to provide an overview of the molecular and cellular characteristics of IL-1β and to describe the existing evidence on the role of this cytokine as a modulator of intestinal homeostasis and an activator of inflammatory responses, in the course of IBD. This evidence concerns the gene IL1B and inflammatory bowel disease.